Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03693469
Other study ID # H18-01851
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date October 1, 2019

Study information

Verified date January 2019
Source University of British Columbia
Contact Ran Goldman, MD
Phone 604-875-2345
Email rgoldman@cw.bc.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Children need routine immunizations which can be a painful procedure associated with pain and anxiety. This is particularly true of children visiting the children's hospital to visit relatives during flu season. No topical anesthetic or oral analgesia is commonly used.

Virtual Reality (VR) is an immersive experience using sight, sound, and position sense. Using VR may enhance distraction during the painful procedure and may reduce attention to pain.

This study will randomize children (6 - 16 years old) to receive Virtual Reality or standard of care while receiving immunizations. Investigators will measure pain, anxiety and satisfaction.


Recruitment information / eligibility

Status Recruiting
Enrollment 64
Est. completion date October 1, 2019
Est. primary completion date October 1, 2019
Accepts healthy volunteers No
Gender All
Age group 6 Years to 16 Years
Eligibility Inclusion Criteria:

1. Children age 6 to 16 years

2. Patients arriving to the immunization clinic for immunization.

3. Parents will sign a consent form and children will sign an assent form

Exclusion Criteria:

1. Children with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay)

2. Facial features or injury prohibiting wearing the VR goggles

3. VR system may interfere with immunization

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Virtual Reality
Participants wear a Virtual Reality headset that consists of a ASUS phone and a VOX+ Z3 3D Virtual Reality Headset. The phone runs the VR Roller Coaster app to produce the virtual environment.

Locations

Country Name City State
Canada BC Children's Hospital Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain using the Faces Pain Scale - Revised Level of pain as reported by children using Faces Pain Scale - Revised. The scale includes six faces that represent progressively more intense features of pain. Children point to the face that best represents their current level of pain. The minimum score is 0 (representing least pain) and the maximum score is 10 (representing greater pain). The scale increase in increments of 2. Pain is reported by children immediately following completion of the immunization (within two minutes post-immunization). This scale should take less than one minute to complete.
Secondary Anxiety using the Venham Situational Anxiety Score Level of Situational Anxiety as reported by children using the Venham Situational Anxiety Score. This scale includes 8 sets of 2 images of children which represent differing levels of anxiety. Children point to the child that best represents them in that instance. In each set of 2 images of children, one represents greater anxiety (scored as 1) and one represents lesser anxiety (scored as 0). The points from each set of images are totaled. The minimum score is 0 (least anxious) and maximum score is 8 (most anxious). Anxiety is reported by children immediately following completion of the immunization (within two minutes post-immunization). This scale should take less than one minute to complete.
Secondary Patient Satisfaction determined by Global Rating Scale Satisfaction from the procedure is determined by asking 4 questions on a global rating scale. This scale goes from 0-10 where 0 represents "not very much" and 10 represents "very much." Questions are developed from previous virtual reality research. "Overall, how satisfied are you with pain management during plastic surgery?" "Overall, how satisfied are you with anxiety management during plastic surgery?" "To what extent did you feel like you went into the virtual world?" "How much fun did you have while playing in the virtual world?" These questions will be analyzed individually not summed. Satisfaction question is reported by children immediately following completion of the immunization (within 5 minutes post immunization)
Secondary Medication Dose How much topical or local anesthetics are used and when they are used (24 hour time); how much sedatives are used and when they are used (24 hour time); how much analgesics are used and when they are used (24 hour time). These will be recorded during the procedure and immediately following the procedure using the patient chart
Secondary Length of time of procedure Time in minutes from readiness for procedure (availability of child, staff and equipment) until completion of procedure (healthcare practitioner does not need to touch the patient anymore) This will be documented during the procedure
See also
  Status Clinical Trial Phase
Completed NCT05009251 - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Completed NCT05012163 - Lottery Incentive Nudges to Increase Influenza Vaccinations N/A
Recruiting NCT05996549 - Cost-effectiveness of the Influenza Vaccination Phase 4
Completed NCT04323137 - Encouraging Flu Vaccination Among High-Risk Patients Identified by ML N/A
Completed NCT01224301 - School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities N/A
Completed NCT00169858 - Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections Phase 4
Completed NCT05509283 - Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications N/A
Completed NCT02907580 - Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric N/A
Recruiting NCT06160999 - Improving Uptake of Pediatric Vaccines Through Religious Conferences and Vaccines-in-a-van in Aceh, Indonesia N/A
Recruiting NCT03875703 - Post-Vaccination Biological Collection
Completed NCT03287830 - Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine N/A
Completed NCT02907645 - Influenza Vaccine Randomized Educational Trial: Adult N/A
Completed NCT03220555 - Efficacy of the Buzzy® Device on the Prevention of Health Care Induced Pediatric Pain in a Vaccination Center N/A
Withdrawn NCT05023512 - Understanding Public Attitudes Towards the COVID-19 Vaccination N/A
Recruiting NCT02937428 - To Look or Not to Look at the Needle During Vaccination Phase 3
Completed NCT00813319 - Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females Phase 3
Completed NCT03104790 - Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls Phase 4
Completed NCT04780867 - Psychological and Lifestyle Factors on Health Outcomes N/A
Completed NCT03239795 - Promoting Influenza Vaccination In General Practice Waiting Rooms N/A